XPO1 and acute myeloid leukemia: Kojima et al. (Kojima et al., 2013) detected the expression level of XPO1 protein in 511 de novo AML patients and variable analysis showed that high expression of XPO1 is an independent predictor of overall survival (OS), which is related to high-risk cytogenetics and shorter survival.